Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term survival in patients discharged alive from hospital following an intensive care unit admission with sepsis or septic shock in Australia and New Zealand: an observational cohort study.

The Lancet regional health. Western Pacific·2026
Same author

Vasopressors or Fluids in Early Septic Shock.

The New England journal of medicine·2026
Same author

Vancomycin-resistant Enterococcus infective endocarditis: A case series and review of the literature.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Socioeconomic disadvantage and sepsis survival in Australian intensive care units: A retrospective cohort study.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2026
Same author

Sustainable continuous renal replacement therapy: The influence of blood flow rates, effluent dose, autoeffluent, and citrate anticoagulation on carbon dioxide emissions.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2026
Same author

A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device Implantation.

Clinical pharmacokinetics·2025

Related Experiment Video

Updated: Jun 3, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.

Jason A Roberts1, Fabio Silvio Taccone, Andrew A Udy

  • 1Burns Trauma and Critical Care Research Centre, The University of Queensland, Level 3, Ned Hanlon Building, Royal Brisbane and Women's Hospital, Butterfield St., Brisbane, Queensland, Australia 4029. j.roberts2@uq.edu.au.

Antimicrobial Agents and Chemotherapy
|March 16, 2011
PubMed
Summary

Higher vancomycin doses are needed for critically ill patients to reach effective serum concentrations quickly. This study suggests increased loading and daily doses improve vancomycin efficacy in this population.

More Related Videos

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

Related Experiment Videos

Last Updated: Jun 3, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

Area of Science:

  • Pharmacology
  • Critical Care Medicine
  • Infectious Diseases

Background:

  • Vancomycin is a primary antibiotic for Gram-positive infections.
  • Rapid achievement of therapeutic vancomycin concentrations is challenging in critically ill patients.

Purpose of the Study:

  • To perform a population pharmacokinetic analysis of vancomycin in critically ill patients.
  • To determine optimal dosing strategies for vancomycin in this population.

Main Methods:

  • Retrospective analysis of 206 adult septic critically ill patients receiving vancomycin.
  • Population pharmacokinetic modeling using NONMEM software.
  • Monte Carlo simulations to evaluate dosing strategies.

Main Results:

  • A one-compartment linear model best described vancomycin pharmacokinetics.
  • Volume of distribution was influenced by total body weight; clearance by creatinine clearance (CrCl).
  • A 35-mg/kg loading dose and 35 mg/kg/day continuous infusion were needed to reach target concentrations (20 mg/L) in patients with CrCl of 100 ml/min/1.73 m².

Conclusions:

  • Higher vancomycin loading and daily doses than currently recommended are necessary for critically ill patients.
  • Optimized dosing is crucial for achieving rapid therapeutic serum concentrations and improving vancomycin efficacy.